All news

IceCure Medical seeks reverse split to keep Nasdaq listing

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

IceCure Medical (ICCM) is asking shareholders to approve a reverse share split of 5-for-1 up to a cumulative 40-for-1 within 24 months, aimed at regaining compliance with Nasdaq's

Read original source

ICCM company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.